Business intelligence reports for the lab diagnostics industry
Subscribe for Exclusive Access.
Subscriptions & Reports
![Mar2022-DTET-Cover](https://g2woo.wpengine.com/wp-content/uploads/2022/03/Mar2022-DTET-Cover.webp)
![March2022-LCA.Cover](https://g2woo.wpengine.com/wp-content/uploads/2022/03/March2022-LCA.Cover_.webp)
![March2022-LIR-Cover](https://g2woo.wpengine.com/wp-content/uploads/2022/03/March2022-LIR-Cover.webp)
![April-2022-NLR-Briefing-Cover](https://g2woo.wpengine.com/wp-content/uploads/2022/03/April-2022-NLR-Briefing-Cover.webp)
Interested in multiple copies or more than one of our G2 reports?
Call Sokha at 855-528-6903 or email spearson@g2intelligence.com to discuss pricing.
No Results Found
The posts you requested could not be found. Try changing your module settings or create some new posts.
No Results Found
The posts you requested could not be found. Try changing your module settings or create some new posts.
No Results Found
The posts you requested could not be found. Try changing your module settings or create some new posts.
Opko Acquires Bio-Reference Laboratories for $1.45 Billion
By Ron Shinkman, Editor, Laboratory Industry Report Opko Health, Inc., the Miami-based molecular lab, has come to an agreement to acquire Bio-Reference Laboratory for $1.47 billion in a stock swap deal. Opko will pay the equivalent of $52.58 per share for...
Multidisciplinary Tumor Panels Could Ease Utility of Genomic Data
By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies Multidisciplinary tumor boards can improve the clinical relevance of information derived from genomic testing, according to presenters at an extended education session "Expediting the Learning...